EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 32021D0184

Commission Implementing Decision (EU) 2021/184 of 12 February 2021 amending Decisions 2009/813/EC, 2009/814/EC and 2010/429/EU and Implementing Decisions 2012/82/EU, 2012/83/EU, 2012/347/EU, 2013/649/EU, (EU) 2015/683, (EU) 2015/684, (EU) 2015/685, (EU) 2015/686, (EU) 2015/687, (EU) 2015/688, (EU) 2015/689, (EU) 2015/693, (EU) 2015/695, (EU) 2015/696, (EU) 2015/700, (EU) 2015/701, (EU) 2015/2279, (EU) 2015/2281, (EU) 2016/1216, (EU) 2016/1217, (EU) 2017/1207, (EU) 2018/1111, (EU) 2018/2045, (EU) 2018/2046, (EU) 2019/1307, (EU) 2019/1308, (EU) 2019/1309, (EU) 2019/2083 and (EU) 2020/1360 as regards the authorisation holder and its representative in the Union for the placing on the market of products containing, consisting of or produced from certain genetically modified organisms (notified under document C(2021) 826) (Only the Dutch text is authentic) (Text with EEA relevance)

C/2021/826

OJ L 55, 16.2.2021, p. 4–23 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

Legal status of the document In force

ELI: http://data.europa.eu/eli/dec_impl/2021/184/oj

16.2.2021   

EN

Official Journal of the European Union

L 55/4


COMMISSION IMPLEMENTING DECISION (EU) 2021/184

of 12 February 2021

amending Decisions 2009/813/EC, 2009/814/EC and 2010/429/EU and Implementing Decisions 2012/82/EU, 2012/83/EU, 2012/347/EU, 2013/649/EU, (EU) 2015/683, (EU) 2015/684, (EU) 2015/685, (EU) 2015/686, (EU) 2015/687, (EU) 2015/688, (EU) 2015/689, (EU) 2015/693, (EU) 2015/695, (EU) 2015/696, (EU) 2015/700, (EU) 2015/701, (EU) 2015/2279, (EU) 2015/2281, (EU) 2016/1216, (EU) 2016/1217, (EU) 2017/1207, (EU) 2018/1111, (EU) 2018/2045, (EU) 2018/2046, (EU) 2019/1307, (EU) 2019/1308, (EU) 2019/1309, (EU) 2019/2083 and (EU) 2020/1360 as regards the authorisation holder and its representative in the Union for the placing on the market of products containing, consisting of or produced from certain genetically modified organisms

(notified under document C(2021) 826)

(Only the Dutch text is authentic)

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modified food and feed (1), and in particular to Article 9(2) and Article 21(2) thereof,

Whereas:

(1)

Bayer Agriculture BVBA, based in Belgium, is the representative of Monsanto Company, based in the United States, concerning 32 authorisations for the placing on the market of products containing, consisting of or produced from certain genetically modified organisms under Regulation (EC) No 1829/2003. The respective authorisations were granted by Commission Decisions 2009/813/EC (2), 2009/814/EC (3) and 2010/429/EU (4) and Commission Implementing Decisions 2012/82/EU (5), 2012/83/EU (6), 2012/347/EU (7), 2013/649/EU (8), (EU) 2015/683 (9), (EU) 2015/684 (10), (EU) 2015/685 (11), (EU) 2015/686 (12), (EU) 2015/687 (13), (EU) 2015/688 (14), (EU) 2015/689 (15), (EU) 2015/693 (16), (EU) 2015/695 (17), (EU) 2015/696 (18), (EU) 2015/700 (19), (EU) 2015/701 (20), (EU) 2015/2279 (21), (EU) 2015/2281 (22), (EU) 2016/1216 (23), (EU) 2016/1217 (24), (EU) 2017/1207 (25), (EU) 2018/1111 (26), (EU) 2018/2045 (27), (EU) 2018/2046, (28) (EU) 2019/1307 (29), (EU) 2019/1308 (30), (EU) 2019/1309 (31), (EU) 2019/2083 (32) and (EU) 2020/1360 (33).

(2)

By letter dated 28 July 2020, Bayer Agriculture BVBA informed the Commission that it changes its name to Bayer Agriculture BV, Belgium, as of 1 August 2020.

(3)

By letter dated 28 July 2020, Bayer Agriculture BVBA informed the Commission that Monsanto Company, United States, converts its legal form and changes its name to Bayer CropScience LP as of 1 August 2020.

(4)

The proposed amendments to the authorisation decisions are purely administrative in nature and do not entail a new assessment of the products concerned.

(5)

Decisions 2009/813/EC, 2009/814/EC and 2010/429/EU, Implementing Decisions 2012/82/EU, 2012/83/EU, 2012/347/EU, 2013/649/EU, (EU) 2015/683, (EU) 2015/684, (EU) 2015/685, (EU) 2015/686, (EU) 2015/687, (EU) 2015/688, (EU) 2015/689, (EU) 2015/693, (EU) 2015/695, (EU) 2015/696, (EU) 2015/700, (EU) 2015/701, (EU) 2015/2279, (EU) 2015/2281, (EU) 2016/1216, (EU) 2016/1217, (EU) 2017/1207, (EU) 2018/1111, (EU) 2018/2045, (EU) 2018/2046, (EU) 2019/1307, (EU) 2019/1308, (EU) 2019/1309, (EU) 2019/2083 and (EU) 2020/1360 should therefore be amended accordingly.

(6)

The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS DECISION:

Article 1

Amendments to Decision 2009/813/EC

Decision 2009/813/EC is amended as follows:

(1)

Article 6 is replaced by the following:

‘Article 6

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 8 is replaced by the following:

‘Article 8

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States.’

Article 2

Amendments to Decision 2009/814/EC

Decision 2009/814/EC is amended as follows:

(1)

Article 6 is replaced by the following:

‘Article 6

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 8 is replaced by the following:

‘Article 8

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 3

Amendments to Decision 2010/429/EU

Commission Decision 2010/429/EU is amended as follows:

(1)

Article 6 is replaced by the following:

‘Article 6

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 8 is replaced by the following:

‘Article 8

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 4

Amendments to Implementing Decision 2012/82/EU

Implementing Decision 2012/82/EU is amended as follows:

(1)

Article 6 is replaced by the following:

‘Article 6

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 9 is replaced by the following:

‘Article 9

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 5

Amendments to Implementing Decision 2012/83/EU

Implementing Decision 2012/83/EU is amended as follows:

(1)

Article 6 is replaced by the following:

‘Article 6

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 8 is replaced by the following:

‘Article 8

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 6

Amendments to Implementing Decision 2012/347/EU

Implementing Decision 2012/347/EU is amended as follows:

(1)

Article 6 is replaced by the following:

‘Article 6

Authorisation holder

The authorisation holder shall be Bayer CropScience LP, United States of America, represented in the Union by Bayer Agriculture BV, Belgium.’;

(2)

Article 8 is replaced by the following:

‘Article 8

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer CropScience LP

Address: 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States

Represented by Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’

Article 7

Amendments to Implementing Decision 2013/649/EU

Implementing Decision 2013/649/EU is amended as follows:

(1)

Article 5 is replaced by the following:

‘Article 5

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 7 is replaced by the following:

‘Article 7

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 8

Amendments to Implementing Decision (EU) 2015/683

Implementing Decision (EU) 2015/683 is amended as follows:

(1)

Article 6 is replaced by the following:

‘Article 6

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 8 is replaced by the following:

‘Article 8

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 9

Amendments to Implementing Decision (EU) 2015/684

Implementing Decision (EU) 2015/684 is amended as follows:

(1)

Article 6 is replaced by the following:

‘Article 6

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 9 is replaced by the following:

‘Article 9

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 10

Amendments to Implementing Decision (EU) 2015/685

Implementing Decision (EU) 2015/685 is amended as follows:

(1)

Article 6 is replaced by the following:

‘Article 6

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 8 is replaced by the following:

‘Article 8

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 11

Amendments to Implementing Decision (EU) 2015/686

Implementing Decision (EU) 2015/686 is amended as follows:

(1)

Article 7 is replaced by the following:

‘Article 7

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 9 is replaced by the following:

‘Article 9

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States.’

Article 12

Amendments to Implementing Decision (EU) 2015/687

Implementing Decision (EU) 2015/687 is amended as follows:

(1)

Article 6 is replaced by the following:

‘Article 6

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 8 is replaced by the following:

‘Article 8

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 13

Amendments to Implementing Decision (EU) 2015/688

Implementing Decision (EU) 2015/688 is amended as follows:

(1)

Article 6 is replaced by the following:

‘Article 6

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 8 is replaced by the following:

‘Article 8

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 14

Amendments to Implementing Decision (EU) 2015/689

Implementing Decision (EU) 2015/689 is amended as follows:

(1)

Article 5 is replaced by the following:

‘Article 5

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 7 is replaced by the following:

‘Article 7

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 15

Amendments to Implementing Decision (EU) 2015/693

Implementing Decision (EU) 2015/693 is amended as follows:

(1)

Article 5 is replaced by the following:

‘Article 5

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 7 is replaced by the following:

‘Article 7

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 16

Amendments to Implementing Decision (EU) 2015/695

Implementing Decision (EU) 2015/695 is amended as follows:

(1)

Article 5 is replaced by the following:

‘Article 5

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 7 is replaced by the following:

‘Article 7

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 17

Amendments to Implementing Decision (EU) 2015/696

Implementing Decision (EU) 2015/696 is amended as follows:

(1)

Article 7 is replaced by the following:

‘Article 7

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 9 is replaced by the following:

‘Article 9

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 18

Amendments to Implementing Decision (EU) 2015/700

Implementing Decision (EU) 2015/700 is amended as follows:

(1)

Article 6 is replaced by the following:

‘Article 6

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 8 is replaced by the following:

‘Article 8

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 19

Amendments to Implementing Decision (EU) 2015/701

Implementing Decision (EU) 2015/701 is amended as follows:

(1)

Article 6 is replaced by the following:

‘Article 6

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 8 is replaced by the following:

‘Article 8

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 20

Amendments to Implementing Decision (EU) 2015/2279

Implementing Decision (EU) 2015/2279 is amended as follows:

(1)

Article 6 is replaced by the following:

‘Article 6

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 8 is replaced by the following:

‘Article 8

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 21

Amendments to Implementing Decision (EU) 2015/2281

Implementing Decision (EU) 2015/2281 is amended as follows:

(1)

Article 6 is replaced by the following:

‘Article 6

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 8 is replaced by the following:

‘Article 8

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 22

Amendments to Implementing Decision (EU) 2016/1216

Implementing Decision (EU) 2016/1216 is amended as follows:

(1)

Article 6 is replaced by the following:

‘Article 6

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 8 is replaced by the following:

‘Article 8

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 23

Amendments to Implementing Decision (EU) 2016/1217

Implementing Decision (EU) 2016/1217 is amended as follows:

(1)

Article 7 is replaced by the following:

‘Article 7

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 9 is replaced by the following:

‘Article 9

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’,

Article 24

Amendments to Implementing Decision (EU) 2017/1207

Implementing Decision (EU) 2017/1207 is amended as follows:

(1)

Article 6 is replaced by the following:

‘Article 6

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 8 is replaced by the following:

‘Article 8

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 25

Amendments to Implementing Decision (EU) 2018/1111

Implementing Decision (EU) 2018/1111 is amended as follows:

(1)

Article 7 is replaced by the following:

‘Article 7

Authorisation holder

The authorisation holder shall be Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

Article 10 is replaced by the following:

‘Article 10

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer Agriculture BV

Address: Scheldelaan 460, 2040 Antwerp, Belgium

On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States’.

Article 26

Amendments to Implementing Decision (EU) 2018/2045

Implementing Decision (EU) 2018/2045 is amended as follows:

(1)

Article 7 is replaced by the following:

‘Article 7

Authorisation holder

The authorisation holder shall be Bayer CropScience LP, United States, represented in the Union by Bayer Agriculture BV, Belgium.’;

(2)

Article 9 is replaced by the following:

‘Article 9

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer CropScience LP

Address: 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States

Represented by Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium’.

Article 27

Amendments to Implementing Decision (EU) 2018/2046

Implementing Decision (EU) 2018/2046 is amended as follows:

(1)

Article 7 is replaced by the following:

‘Article 7

Authorisation holder

The authorisation holder shall be Bayer CropScience LP, United States, represented in the Union by Bayer Agriculture BV, Belgium.’;

(2)

Article 10 is replaced by the following:

‘Article 10

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer CropScience LP

Address: 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States

Represented by Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium’.

Article 28

Amendments to Implementing Decision (EU) 2019/1307

Implementing Decision (EU) 2019/1307 is amended as follows:

(1)

Article 7 is replaced by the following:

‘Article 7

Authorisation holder

The authorisation holder shall be Bayer CropScience LP, United States, represented in the Union by Bayer Agriculture BV, Belgium.’;

(2)

Article 9 is replaced by the following:

‘Article 9

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer CropScience LP

Address: 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States

Represented by Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium’.

Article 29

Amendments to Implementing Decision (EU) 2019/1308

Implementing Decision (EU) 2019/1308 is amended as follows:

(1)

Article 7 is replaced by the following:

‘Article 7

Authorisation holder

The authorisation holder shall be Bayer CropScience LP, United States, represented in the Union by Bayer Agriculture BV, Belgium.’;

(2)

Article 9 is replaced by the following:

‘Article 9

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer CropScience LP

Address: 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States

Represented by Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium’.

Article 30

Amendments to Implementing Decision (EU) 2019/1309

Implementing Decision (EU) 2019/1309 is amended as follows:

(1)

Article 7 is replaced by the following:

‘Article 7

Authorisation holder

The authorisation holder shall be Bayer CropScience LP, United States, represented in the Union by Bayer Agriculture BV, Belgium.’;

(2)

Article 9 is replaced by the following:

‘Article 9

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer CropScience LP

Address: 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States

Represented by Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium’.

Article 31

Amendments to Implementing Decision (EU) 2019/2083

Implementing Decision (EU) 2019/2083 is amended as follows:

(1)

Article 7 is replaced by the following:

‘Article 7

Authorisation holder

The authorisation holder shall be Bayer CropScience LP, United States, represented in the Union by Bayer Agriculture BV, Belgium.’;

(2)

Article 9 is replaced by the following:

‘Article 9

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer CropScience LP

Address: 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States

Represented by Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium’.

Article 32

Amendments to Implementing Decision (EU) 2020/1360

Implementing Decision (EU) 2020/1360 is amended as follows:

(1)

Article 7 is replaced by the following:

‘Article 7

Authorisation holder

The authorisation holder shall be Bayer CropScience LP, United States of America, represented by Bayer Agriculture BV, Belgium.’;

(2)

Article 9 is replaced by the following:

‘Article 9

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a) of the Annex is replaced by the following:

‘(a)

Applicant and authorisation holder:

Name: Bayer CropScience LP

Address: 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States of America

Represented by Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’

Article 33

Addressee

This Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.

Done at Brussels, 12 February 2021.

For the Commission

Stella KYRIAKIDES

Member of the Commission


(1)   OJ L 268, 18.10.2003, p. 1.

(2)  Commission Decision 2009/813/EC of 30 October 2009 authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize MON 89034 (MON-89Ø34-3) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 289, 5.11.2009, p. 21).

(3)  Commission Decision 2009/814/EC of 30 October 2009 authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize MON 88017 (MON-88Ø17-3) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 289, 5.11.2009, p. 25).

(4)  Commission Decision 2010/429/EU of 28 July 2010 authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize MON 88017 x MON 810 (MON-88Ø17-3 x MON-ØØ81Ø-6) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 201, 3.8.2010, p. 46).

(5)  Commission Implementing Decision 2012/82/EU of 10 February 2012 as regards the renewal of the authorisation for continued marketing of products containing, consisting of, or produced from genetically modified soybean 40-3-2 (MON-Ø4Ø32-6) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 40, 14.2.2012, p. 14).

(6)  Commission Implementing Decision 2012/83/EU of 10 February 2012 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean MON 87701 (MON-877Ø1-2) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 40, 14.2.2012, p. 18).

(7)  Commission Implementing Decision 2012/347/EU of 28 June 2012 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean MON 87701 × MON 89788 (MON-877Ø1-2 × MON-89788-1) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 171, 30.6.2012, p. 13).

(8)  Commission Implementing Decision 2013/649/EU of 6 November 2013 authorising the placing on the market of pollen produced from maize MON 810 (MON-ØØ81Ø-6) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 302, 13.11.2013, p. 44).

(9)  Commission Implementing Decision (EU) 2015/683 of 24 April 2015 authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize MON 87460 (MON 8746Ø-4) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 112, 30.4.2015, p. 1).

(10)  Commission Implementing Decision (EU) 2015/684 of 24 April 2015 authorising the placing on the market of genetically modified maize NK603 (MON-ØØ6Ø3-6) and renewing the existing maize NK603 (MON-ØØ6Ø3-6) products, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 112, 30.4.2015, p. 6).

(11)  Commission Implementing Decision (EU) 2015/685 of 24 April 2015 authorising the placing on the market of genetically modified cotton MON 15985 (MON-15985-7) and renewing the authorisation for existing genetically modified cotton MON 15985 (MON-15985-7) products pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 112, 30.4.2015, p. 11).

(12)  Commission Implementing Decision (EU) 2015/686 of 24 April 2015 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean MON 87769 (MON-87769-7) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 112, 30.4.2015, p. 16).

(13)  Commission Implementing Decision (EU) 2015/687 of 24 April 2015 authorising the placing on the market of products containing, consisting of, or produced from genetically modified oilseed rape MON 88302 (MON-883Ø2-9) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 112, 30.4.2015, p. 22).

(14)  Commission Implementing Decision (EU) 2015/688 of 24 April 2015 authorising the placing on the market of products containing, consisting of, or produced from genetically modified cotton MON 88913 (MON-88913-8) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 112, 30.4.2015, p. 26).

(15)  Commission Implementing Decision (EU) 2015/689 of 24 April 2015 renewing the authorisation for existing genetically modified cotton MON 531 (MON-ØØ531-6) products pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 112, 30.4.2015, p. 31).

(16)  Commission Implementing Decision (EU) 2015/693 of 24 April 2015 renewing the authorisation for existing genetically modified cotton MON 1445 (MON-Ø1445-2) products pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 112, 30.4.2015, p. 48).

(17)  Commission Implementing Decision (EU) 2015/695 of 24 April 2015 renewing the authorisation for existing genetically modified cotton MON 531 x MON 1445 (MON-ØØ531-6 x MON-Ø1445-2) products and authorising the placing on the market of cottonseed oil produced from genetically modified cotton MON 531 x MON 1445 (MON-ØØ531-6 x MON-Ø1445-2) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 112, 30.4.2015, p. 56).

(18)  Commission Implementing Decision (EU) 2015/696 of 24 April 2015 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean MON87705 (MON-877Ø5-6) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 112, 30.4.2015, p. 60).

(19)  Commission Implementing Decision (EU) 2015/700 of 24 April 2015 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean MON87708 (MON-877Ø8-9) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 112, 30.4.2015, p. 81).

(20)  Commission Implementing Decision (EU) 2015/701 of 24 April 2015 authorising the placing on the market of food containing or consisting of genetically modified oilseed rape GT73, or food and feed produced from that genetically modified organism pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 112, 30.4.2015, p. 86).

(21)  Commission Implementing Decision (EU) 2015/2279 of 4 December 2015 authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize NK603 × T25 (MON-ØØ6Ø3-6 × ACS-ZMØØ3-2) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 322, 8.12.2015, p. 58).

(22)  Commission Implementing Decision (EU) 2015/2281 of 4 December 2015 authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize MON 87427 (MON-87427-7) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 322, 8.12.2015, p. 67).

(23)  Commission Implementing Decision (EU) 2016/1216 of 22 July 2016 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean MON 87708 × MON 89788 (MON-877Ø8-9 × MON-89788-1) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 199, 26.7.2016, p. 22).

(24)  Commission Implementing Decision (EU) 2016/1217 of 22 July 2016 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean MON 87705 × MON 89788 (MON-877Ø5-6 × MON-89788-1) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 199, 26.7.2016, p. 28).

(25)  Commission Implementing Decision (EU) 2017/1207 of 4 July 2017 renewing the authorisation for the placing on the market of genetically modified maize MON 810 (MON-ØØ81Ø-6) products pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 173, 6.7.2017, p. 18).

(26)  Commission Implementing Decision (EU) 2018/1111 of 3 August 2018 authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize MON 87427 × MON 89034 × NK603 (MON-87427-7 × MON-89Ø34-3 × MON-ØØ6Ø3-6) and genetically modified maize combining two of the events MON 87427, MON 89034 and NK603, and repealing Decision 2010/420/EU (OJ L 203, 10.8.2018, p. 20).

(27)  Commission Implementing Decision (EU) 2018/2045 of 19 December 2018 renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize NK603 × MON 810 (MON-ØØ6Ø3-6 × MON-ØØ81Ø-6) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 327, 21.12.2018, p. 65).

(28)  Commission Implementing Decision (EU) 2018/2046 of 19 December 2018 authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 87427 × MON 89034 × 1507 × MON 88017 × 59122, and genetically modified maize combining two, three or four of the single events MON 87427, MON 89034, 1507, MON 88017 and 59122 and repealing Decision 2011/366/EU (OJ L 327, 21.12.2018, p. 70).

(29)  Commission Implementing Decision (EU) 2019/1307 of 26 July 2019 authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 87403 (MON-874Ø3-1), pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 204, 2.8.2019, p. 81).

(30)  Commission Implementing Decision (EU) 2019/1308 of 26 July 2019 authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 87411 (MON-87411-9), pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 204, 2.8.2019, p. 85).

(31)  Commission Implementing Decision (EU) 2019/1309 of 26 July 2019 authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 87751 (MON-87751-7), pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 204, 2.8.2019, p. 90).

(32)  Commission Implementing Decision (EU) 2019/2083 of 28 November 2019 renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 89788 (MON-89788-1) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 316, 6.12.2019, p. 68).

(33)  Commission Implementing Decision (EU) 2020/1360 of 28 September 2020 authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 87708 × MON 89788 × A5547-127, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ L 316, 30.9.2020, p. 1).


Top